Sophiris Bio (SHS-T) Stock Predictions - Stockchase
WATCH LIST
1
Sophiris Bio (SHS-T)

ON STOCKCHASE SINCE Mar 2008

Name changed from Protox Therapeutics (2012)

Voluntarily de-listed from TSX (Nov 2013)

Consumer Products

Sophiris Bio

SHS-T

1 watching          
Join the Discussion

Sophiris Bio (SHS-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about SHS-T



  • All
  • Filtered
Signal Opinion Expert
VAGUE
Sophiris Bio(SHS-T) 

March 26, 2008

A drug that corrects complications that occur with the prostrate and prostrate cancer. Entering phase 2 clinical trials, has large market opportunities. Have done safety studies. In good shape regarding their cash position.
Consumer Products
0 0 0 0 0
0 comments
A drug that corrects complications that occur with the prostrate and prostrate cancer. Entering phase 2 clinical trials, has large market opportunities. Have done safety studies. In good shape regarding their cash position.
Consumer Products
0 0 0 0 0
0 comments
Geoff Houlton

Senior Hea, Union Securities...

Price Price
$0.840
Owned Owned
Unknown

Showing 1 to 1 of 1 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days